231 related articles for article (PubMed ID: 15897859)
1. Oral inflammatory myofibroblastic tumor demonstrating ALK, p53, MDM2, CDK4, pRb, and Ki-67 immunoreactivity in an elderly patient.
Brooks JK; Nikitakis NG; Frankel BF; Papadimitriou JC; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jun; 99(6):716-26. PubMed ID: 15897859
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
Qiu X; Montgomery E; Sun B
Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory myofibroblastic tumor of paranasal sinuses.
Al-Sindi K; Al-Shehabi MH; Al-Khalifa SA
Saudi Med J; 2007 Apr; 28(4):623-7. PubMed ID: 17457491
[TBL] [Abstract][Full Text] [Related]
4. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract][Full Text] [Related]
5. A successfully treated inflammatory myofibroblastic tumor of the mandible with long-term follow-up and review of the literature.
Satomi T; Watanabe M; Matsubayashi J; Nagao T; Chiba H
Med Mol Morphol; 2010 Sep; 43(3):185-91. PubMed ID: 20857269
[TBL] [Abstract][Full Text] [Related]
6. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.
Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW
Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
[TBL] [Abstract][Full Text] [Related]
8. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.
Yamamoto H; Oda Y; Saito T; Sakamoto A; Miyajima K; Tamiya S; Tsuneyoshi M
Histopathology; 2003 May; 42(5):431-9. PubMed ID: 12713619
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
[TBL] [Abstract][Full Text] [Related]
10. The immunohistochemical profile of oral inflammatory myofibroblastic tumors.
Salgueiredo-Giudice F; Fornias-Sperandio F; Martins-Pereira E; da Costa dal Vechio AM; de Sousa SC; dos Santos-Pinto-Junior D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jun; 111(6):749-56. PubMed ID: 21459633
[TBL] [Abstract][Full Text] [Related]
11. Calcifying fibrous pseudotumor versus inflammatory myofibroblastic tumor: a histological and immunohistochemical comparison.
Hill KA; Gonzalez-Crussi F; Chou PM
Mod Pathol; 2001 Aug; 14(8):784-90. PubMed ID: 11504838
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical comparison of p53, Ki-67, CD68, vimentin, α-smooth muscle actin and alpha-1-antichymotry-psin in oral peripheral and central giant cell granuloma.
Kujan O; Al-Shawaf AZ; Azzeghaiby S; AlManadille A; Aziz K; Raheel SA
J Contemp Dent Pract; 2015 Jan; 16(1):20-4. PubMed ID: 25876945
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
Zhang YH; Zhang XR; Yu J; Li HL
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662
[No Abstract] [Full Text] [Related]
14. An isolated inflammatory myofibroblastic tumor of adrenal gland.
Al Sannaa G; Wimmer JL; Ayala AG; Ro JY
Ann Diagn Pathol; 2016 Dec; 25():33-36. PubMed ID: 27806843
[TBL] [Abstract][Full Text] [Related]
15. Fine needle aspiration biopsy and immunostaining findings in an aggressive inflammatory myofibroblastic tumor of the lung: a case report.
Hannah CD; Oliver DH; Liu J
Acta Cytol; 2007; 51(2):239-43. PubMed ID: 17425213
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms.
Iczkowski KA; Shanks JH; Gadaleanu V; Cheng L; Jones EC; Neumann R; Nascimento AG; Bostwick DG
Mod Pathol; 2001 Oct; 14(10):1043-51. PubMed ID: 11598176
[TBL] [Abstract][Full Text] [Related]
17. ALK-1 positive orbital inflammatory myofibroblastic tumour (IMT) associated with prominent numbers of IgG4 plasma cells - a case report.
Mudhar HS; Nuruddin M
Orbit; 2013 Oct; 32(5):321-3. PubMed ID: 23927068
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory myofibroblastic tumor of the alveolar mucosa of the mandible.
Johann AC; Caldeira PC; Abdo EN; Sousa SO; Aguiar MC; Mesquita RA
Minerva Stomatol; 2008; 57(1-2):59-63. PubMed ID: 18427372
[TBL] [Abstract][Full Text] [Related]
19. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors.
Hussong JW; Brown M; Perkins SL; Dehner LP; Coffin CM
Mod Pathol; 1999 Mar; 12(3):279-86. PubMed ID: 10102613
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory fibrosarcoma: update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors.
Meis-Kindblom JM; Kjellström C; Kindblom LG
Semin Diagn Pathol; 1998 May; 15(2):133-43. PubMed ID: 9606804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
